メニュー 戻るLS24 Novel Strategy of Clinical Pharmacology in Global Clinical Development: Contribution to Worldwide Simultaneous NDA Submission and Approval

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS24 Novel Strategy of Clinical Pharmacology in Global Clinical Development: Contribution to Worldwide Simultaneous NDA Submission and Approval

Session Chair(s)

Yuji  Kumagai, MD, PhD

Yuji Kumagai, MD, PhD

  • Professor, Kitasato Clinical Research Center
  • Kitasato University Hospital, Japan

Speaker(s)

Naoki  Kotani, MSc

Naoki Kotani, MSc

  • Clinical Pharmacologist
  • Chugai Pharmaceutical Co., Ltd., Japan
Kei  Fukuhara, MSc

Kei Fukuhara, MSc

  • Manager, Clinical Pharmacology
  • Pfizer R&D Japan, Japan
Naoki  Uchida, MD, PhD

Naoki Uchida, MD, PhD

  • Professor, Department of Clinical Pharmacology
  • Showa University, School of Medicine, Japan